Antagonizing Wnt pathway in diabetic retinopathy.

about

LRP-1 Pathway Targeted Inhibition of Vascular Abnormalities in the Retina of Diabetic Mice.

P2860

Q33878527-6EECE24B-4093-435E-B049-7BA90D543990

P2860

Antagonizing Wnt pathway in diabetic retinopathy.

Item

http://www.wikidata.org/entity/Q42149497

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Antagonizing Wnt pathway in diabetic retinopathy.

@en

Antagonizing Wnt pathway in diabetic retinopathy.

@nl

type

Item

label

Antagonizing Wnt pathway in diabetic retinopathy.

@en

Antagonizing Wnt pathway in diabetic retinopathy.

@nl

prefLabel

Antagonizing Wnt pathway in diabetic retinopathy.

@en

Antagonizing Wnt pathway in diabetic retinopathy.

@nl

P1476

Antagonizing Wnt pathway in diabetic retinopathy.

@en

P2093

Jacqueline Pei

http://www.w3.org/2001/XMLSchema#string

Kang Zhang

http://www.w3.org/2001/XMLSchema#string

Ling Zhao

http://www.w3.org/2001/XMLSchema#string

Sherrina H Patel

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q.

Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair

Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor

Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis

Pharmacologic therapies for diabetic retinopathy and diabetic macular edema

Blocking the Wnt pathway, a unifying mechanism for an angiogenic inhibitor in the serine proteinase inhibitor family.

Kallistatin antagonizes Wnt/β-catenin signaling and cancer cell motility via binding to low-density lipoprotein receptor-related protein 6

Kallistatin in human ocular tissues: reduced levels in vitreous fluids from patients with diabetic retinopathy.

Identification of a novel inhibitor of the canonical Wnt pathway.

Therapeutic potential of a monoclonal antibody blocking the Wnt pathway in diabetic retinopathy

P304

3993-3995

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB13-1309

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258829608

http://www.w3.org/2001/XMLSchema#string

P698

24264398

http://www.w3.org/2001/XMLSchema#string

P932

3837055

http://www.w3.org/2001/XMLSchema#string

Antagonizing Wnt pathway in diabetic retinopathy.

about

P2860

P2860

Antagonizing Wnt pathway in diabetic retinopathy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932